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Abstract
According to World Malaria Report 2020, the rate of decline in malaria case 
incidence and deaths caused by malaria has ceased in latter half of the past decade. 
Though Artemisinin Combination Therapy (ACT) is still the major therapeutic 
approach globally to treat malaria patients, increased resistance of Plasmodium 
sp. to artemisinin can be looked upon as a major factor responsible for the rate of 
decline. In the present world, immunotherapeutic approaches are in the limelight 
to treat several infections, autoimmune disorders, cancers but application of such 
therapeutic measures in case of malaria are yet not available. Among different 
immune cells, T-regulatory cells (T-reg) and Th-17 cells and the balance between 
them, helps in determining the outcome of the immune response in host during 
both lethal and non-lethal malaria. TGFβ and IL-6 are two major cytokines that play 
important role in fine tuning the Treg/Th-17 balance by modulating dendritic cell 
responses, specially by regulating the ratio between myeloid DC and plasmacytoid 
DC (mDC/pDC). Studies in rodent malaria models have revealed that neutraliza-
tion of IL-6 by using anti IL-6 monoclonal antibodies in-vivo has been found effec-
tive in declining the parasitemia, malaria induced deaths and also in reverting back 
the altered T-reg/Th-17 balance to normal levels. Apart from these, autophagy is 
one of the major factors which also contributes to regulate the T-reg/Th-17 balance. 
In malaria infected mice, autophagy induction has been found to normalise the 
dysregulated T-reg/Th-17 ratio and promote anti-inflammatory Th-2 pathway by 
supressing pro-inflammatory Th-1 pathway. So, Treg/Th-17 balance and its associ-
ated regulators can be important immunotherapeutic targets for malaria prevention 
in near future.
Keywords: Malaria, drug resistance, immunotherapy, T regulatory cells, Th-17, IL-6, 
TGFβ, dendritic cells, autophagy
1. Introduction
World Malaria Report 2020 published by World Health Organization estimated 
229 million cases of malaria infection around the world in 2019 among which 94% 
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of the cases were reported from the WHO African region. The number of estimated 
cases globally in 2019 was 1 million more than that of the previous year. But in the 
context of last 20 years, the number of the existing malaria cases has declined from 
238 million in 2000. Besides, the total number of estimated cases globally, another 
parameter that has been in the centre of studying the impact of this disease is, 
malaria case incidence (cases per 1000 population at risk). Malaria case incidence 
reduced from 80 in 2000 to 57 in 2019 globally but the rate of decline has ceased 
in the latter half of the past decade. The deaccelerating rate of decline has also 
been found in case of malaria mortality rate (i.e. deaths per 100000 population at 
risk). Despite the steady reduction in number of malaria induced deaths in the past 
two decades, more than 400 thousand malaria deaths have been reported in 2019. 
Children aged below 5 years account for 67% of the total malaria deaths, which is a 
major concern [1].
Among various Plasmodium strains that can infect human beings, cerebral 
malaria causing Plasmodium falciparum bring about majority of malaria deaths 
in Africa and parts of Asia. Apart from Plasmodium falciparum, another strain, 
Plasmodium vivax also cause malaria deaths in various other parts of the world  
[2, 3]. Among several available therapeutic and controlling measures, Artemisinin 
based Combination Therapy (ACT) is being used worldwide and has been of great 
success in combating this disease [4–6]. But in recent times, the use of ACT got a 
major setback due to emergence of Artemisinin resistant Plasmodium strains [7, 8]. 
It may be one of the plausible causes behind the diminishing rate of decline in the 
rate of malaria case incidence and malaria mortality rate since 2015. Researchers 
worldwide are putting up constant efforts on making ACT more effective and find-
ing other therapeutic strategies to combat this disease in order to eradicate it in near 
future. Among other therapeutic measures, immunotherapy has been the prime 
focus of study over the past decade. Nowadays immunotherapy is being used for 
various infectious diseases and cancer therapy and the success rate of such thera-
pies are quite promising [9–11]. In case of malaria, immunotherapeutic strategies 
are not yet available for use. This compels researchers worldwide to find various 
molecules or cells that can be targeted for effective therapeutic measures in malaria 
infection [12].
In malaria different stages of the parasitic life cycle can trigger both the innate 
and adaptive immune response within the host. It is quite difficult to study 
whether the immune cells play protective or pathogenic or dual roles, especially 
in human [13]. Still, long-term research reveals specific roles of antibodies and B 
cells in protection of the host body against the malaria parasite. Besides, several 
other immune cells like inflammatory cytokines (TNF α, TGFβ, IFN-γ etc.), 
different subsets of T cells (T-helper cells and Cytotoxic T cells), NK cells and 
Macrophages also play their part in protection or pathogenesis or both depending 
on the type of malaria parasite and the stage of life cycle they are in [14]. During 
life cycle of Plasmodium sp. within the host, several major organs and the immune 
environment within those organs show changes due to presence of parasite fac-
tors. Spleen, being a major lymphoid organ and the main blood filtration unit, 
harbours most of these immune cells [15, 16]. In presence of Plasmodium sp. in 
host body, the immune environment changes rapidly in a day specific manner 
post infection. Investigation of the changes and regulatory mechanisms within 
splenic compartment during infections in humans is difficult for several reasons. 
Most of the study is restricted to observations of clinical symptoms and analysis 
of tissue sections that are available only after post-mortem. So, there is always 
lack of enough samples available to investigate the changes and their associated 
mechanisms in spleen and other lymphoid organs properly [17, 18]. To overcome 
this, researchers worldwide have focused on studying the major changes in 
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rodent models of malaria. Murine malaria models are very much in use for their 
ready availability. Various rodent specific parasite strains like Plasmodium berghei 
ANKA, Plasmodium yoelii, Plasmodium chabaudi are constantly used in labora-
tories and they almost resemble different parameters (i.e. anaemia, body tem-
perature changes, loss of weight, and occasional death) shown by human during 
malaria infection. Apart from these basic parameters, several immune parameters 
like changes in T helper cell and Cytotoxic T cell percentages in lymphoid organs, 
activities of B cell, concentration of antibodies, disruption of blood brain bar-
rier and migration of immune cells in the brain during cerebral malaria infection 
also show resemblance to that of human malaria infections. Plasmodium berghei 
ANKA and Plasmodium chabaudi infections show similar symptoms, immunologi-
cal changes as discussed with that of Plasmodium falciparum infection in human 
which might be due to similarities in infective strategies. Both these rodent and 
human strains can disrupt the blood brain barrier in a similar manner and immune 
cells (majorly T cells) infiltrate in the brain which can be lethal to the respective 
hosts. Another rodent specific non-lethal strain Plasmodium yoelii has similar 
effect on the host immune system to that of Plasmodium vivax infection in humans 
[19]. Working with these rodent strains of Plasmodium sp. has been found effec-
tive in inferring how the immune system is being regulated during malaria and 
the elaborated regulatory mechanisms that controls the inflammatory balance that 
occurs. The balance between pro-inflammatory and regulatory immune responses 
determines the outcome of malaria infection [20]. The balance is maintained by 
various cytokines, chemokines, several immune cells (macrophages, dendritic 
cells) and processes like autophagy. The role of CD4+ T helper cells and CD8+ 
cytotoxic T cells has been found important in regulating the immune response 
during malaria infection using both rodent models and human samples. The focus 
has now been shifted to find out the exact role of different subsets of CD4+ T 
helper cells and how the balance between them defines the outcome of malaria 
infection. Among these subsets, Th1/Th2 balance and the cytokines regulating 
this balance has been found crucial for monitoring the immune homeostasis  
[21, 22]. But recently, balance between two other subsets of T helper cells was 
found to be important in regulation of immune responses in various infections, 
autoimmunity and also cancer immunology. These are termed as T regulatory 
cells that regulates immune-tolerance by secretion of IL-10 and Th17 cells which 
inflicts inflammatory responses by secreting IL-17, IL-22, IL-23. Naïve CD4+ T 
cells differentiate into T-regulatory cells (T-reg) in presence of TGFβ and into 
Th-17 in presence of TGFβ and IL-6. Majority of functions executed by these cells 
are regulated by their major transcription factors FOXP3 and RORγT for T-reg and 
Th17 cells respectively [23–25]. As discussed, the differentiation of Treg and Th17 
cells is reciprocally regulated by shared and different cytokines and recent studies 
even show the plasticity of these cells which states that each subset can convert 
itself to the other one under different inflammatory stimuli [26–28]. These stimuli 
modulates the cytokine environment of the host and also changes the homeostatic 
balance between pro-inflammatory and anti-inflammatory cytokines that culmi-
nates into Treg/Th17 disbalance. So, T-reg/Th17 balance and regulation of factors 
that influence this balance has been found to be pivotal in several viral, bacterial 
and parasitic infections. In case of several autoimmune disorders like rheumatoid 
arthritis (RA), psoriasis, inflammatory bowel disease (IBD), multiple sclerosis 
(MS), Th-17 is the major role player and the T-reg/Th-17 balance skews towards 
pro-inflammatory Th-17 mediated response. Therapeutic approaches which target 
Th-17 cells and its functional transcription factor RORγT has been successful in 
reverting the T-reg/Th-17 cell ratio to normal levels [29]. Monoclonal antibodies 
designed against the human IL-6R, and drugs like sarilumab and tocilizumab 
Plasmodium Species and Drug Resistance
4
can reduce Th-17 cells and increase T-reg cells that helps in amelioration of RA 
in humans [30]. In malaria, the T-reg cells has been found to help the malaria 
parasite to evade the immune response [31]. Apart from T-regs, Th-17 cells have 
been also known to play an important role in blood brain barrier disruption, which 
is a prime reason behind deaths due to cerebral malaria. This article summarizes 
the recent advancements on understanding Treg/Th-17 balance with respect to 
malaria [32].
2. Differential role of T-regulatory cells and Th-17 cells in malaria
During malaria, failure in development of an effective pro-inflammatory and 
anti-inflammatory balance has been found to contribute towards unrestricted 
replication of parasite and severe immunopathology [31, 33]. Several subsets of 
T cells (Th-1, Th-2, NKT cells) are involved in controlling the lethal and non-
lethal malaria infection [34]. T-reg cells have been primarily found to control the 
immune evading mechanism of the Plasmodium sp. in both mouse and human 
[35]. A number of other studies have also reported that T-regs may play an impor-
tant part in facilitating parasite clearance and enhance parasite burden [36, 37]. 
However, in a separate study, depletion of Foxp3+ T-regs failed to provide protec-
tion against experimental cerebral malaria (ECM), which questions the actual role 
of T-regs in lethal and non-lethal malaria [38]. Augmented generation of Th-17 
cells and quick death due to high inflammation in several organs in adult healthy 
mice upon ablation of T-reg cells, point towards a counter regulatory pathway that 
might control the pathogenic Th-17 pathway [39]. Th-17 cell itself and cytokines 
associated with its differentiation from naïve CD4+ T cells has been found to play 
a role in blood brain barrier (BBB) disruption and cooperate with each other to 
allow migration of T cells into the brain [40]. As BBB disruption is a salient feature 
of lethal cerebral malaria, Th-17 pathway and its probable counter regulatory 
pathway controlled by T-regulatory cells is thought to be important in depicting 
the probable outcome of the immune response elicited by the host against the 
malaria parasite. In malaria, the balance between pro-inflammatory and anti-
inflammatory factors was found to be important when we reported differential 
expressions of anti-inflammatory TGFβ and pro-inflammatory TNFα and their 
role in regulation of splenocyte apoptosis [41]. Keeping the outcome of evaluation 
of TGFβ and TNFα in context to splenocyte apoptosis and shared requirements 
of TGFβ during differentiation of T-regs and Th-17 cells, we checked whether 
the balance between anti-inflammatory T regulatory cells and pro-inflammatory 
Th-17 cells (T-reg/Th-17) is important in malaria immunology in both spleen and 
brain. T regulatory cells were found to increase in spleen of non-lethal P. yoelii 
infection at 8 days post infection (dpi) in a day specific manner but in case of 
lethal P. berghei ANKA infection, it decreased with an increase in the infection 
and the percentage of T-regs in spleen was lowest at 8 dpi. Not only Tregs but the 
transcription factors, specially FOXP3 also showed similar trend in spleen of lethal 
and non-lethal malaria infection. In contrast to the T-regulatory cells, Th-17 cells 
increased significantly at 8 dpi in lethal P. berghei ANKA infection but decreased 
optimally at 8 dpi after an initial surge at 2 dpi. The major transcription factor of 
Th-17 cells shows the similar trend in both lethal and non-lethal malaria infection 
as does Th-17 cells [42]. Not only in spleen but also in cerebral cortex and cerebel-
lum of the P. berghei ANKA infected mice, differential expression of FOXP3 and 
RORγT has been found to be critical in regulating the glial cell mediated neuro-
inflammation and neuronal cell death [43]. So, the contrasting behaviour shown 
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by these two cells and their transcription factors highlights the importance of 
T-reg/Th-17 balance and their regulators in malaria.
3.  Role of cytokines (TGFβ and IL-6) in regulation of T-reg/Th-17 
balance in malaria
TGFβ and IL-6 are cytokines that play major roles in the regulation of innate 
and adaptive immune responses in different viral (viz. influenza A, Respiratory 
Syncytical virus etc.), bacterial (viz. Streptococcus, Mycobacterium etc), parasitic 
(viz. Leishmania, Trypanosoma, Toxoplasma etc.) infections, cancers and auto-
immune disorders [44–47]. In malaria, IL-6 is found in circulation of patients 
infected with Plasmodium vivax and Plasmodium falciparum and it plays a major 
role in host response [48–50]. There are reports stating that decreased IL-6 lev-
els upon treatment with anti-malarial compounds is associated with decreased 
parasitaemia [51–53]. However, several reports raise question on actual involve-
ment of IL-6 in the pathogenesis of cerebral malaria [54–56]. In case of TGFβ, we 
have found that low concentration of TGFβ was found to be pro-inflammatory 
where high concentration of TGFβ have anti-inflammatory effects [41]. So, as 
factors responsible for disease outcome in malaria, both of these cytokines and 
their regulatory effect on T-reg/Th-17 balance seem to be important. We neutral-
ized TGFβ and IL-6 by administration of neutralizing antibodies in-vivo at specific 
concentration. Parasitaemia was highest in TGFβ neutralized group than any other 
groups whereas parasitaemia was lowest in IL-6 neutralized group. This has been 
supported by the results of survival percentages of mice, where TGFβ neutralized 
group showed lowest survival percentage and IL-6 neutralized group showed the 
highest survival percentage of mice. Thus, it is quite evident that TGFβ and IL-6 
directly affects the outcome of the immune response elicited by the host in malaria. 
Focusing on the effect of these two cytokines on the T-reg/Th-17 balance, it is 
found that neutralization of TGFβ results in significant induction of Th-17 cells 
at 8 dpi than control and infected ones. Whereas neutralization of IL-6 causes 
reduction in percentage and number of Th-17 cells than Plasmodium berghei ANKA 
infected group. Analysis of percentage and number of T regulatory cells in spleen 
show the reverse phenomenon to that of Th-17 cells upon neutralization of TGFβ 
and IL-6. Thus T-reg/Th-17 balance, which is skewed towards Th-17 in Plasmodium 
berghei ANKA infection is dependent on fine tuning maintained by TGFβ and IL-6. 
IL-6 neutralization reverts the dysregulated T-reg/Th-17 balance to homeostatic 
levels by inhibiting Th17 induction, but neutralization of TGFβ has opposing effect 
and causes the balance to skew more towards Th17. These changes in T-reg/Th17 
balance by regulatory effects of TGFβ and IL-6 is mainly maintained by expression 
of STAT3 and STAT5, which are the major signalling molecules that take part in 
the signalling mechanism of these two cytokines [57]. Neutralization of TGFβ and 
IL-6 not only have its impact on splenic T-reg/Th-17, but also in that of cerebral 
cortex and cerebellum. In Anti-IL-6 treated Plasmodium berghei ANKA infected 
mice, glial cell mediated neuroinflammation is reduced whereas the anti-TGFβ 
treated mice upon infection show similar level of neuroinflammation as that of 
only infected mice. Consistent to that, astrocyte and microglia activation levels 
show similar changes in IL-6 and TGFβ neutralized groups. Regarding T-reg/Th-17, 
the major transcription factor of T-reg cells, FOXP3 expression was significantly 
higher in Anti-IL-6 treated infected group and significantly lower in Anti-TGFβ 
treated infected mice. The expression of IL-17, a major cytokine secreted by Th-17 
cells, show the opposite result to that of FOXP3 in both the groups than the only 
Plasmodium Species and Drug Resistance
6
Plasmodium berghei ANKA infected ones [43]. But the actual percentages of the 
T-reg and Th-17 in cerebral cortex and cerebellum and their changes upon neutral-
ization of these two cytokines is not yet investigated. Though there are few reports 
that cerebral malaria development is independent of IL-17 [58], several other 
reports shows that significant amount of IL-17 is found in circulation of malaria 
infected mice and human patients [59–61]. Genetic variants of IL-17 and its recep-
tor IL-17RA increase the risk of malaria as investigated in African population [62]. 
Protective role of IL-17 during malaria pathogenesis has been found by working 
with IL-17RA deficient mice, in which IL-17 doesn’t function in a proper way. 
These IL-17RA deficient mice show increased parasitemia, earlier onset of malaria, 
increased mortality during acute stage than the wild type mice [63]. So, it can be 
summarised that IL-17 itself and IL-17 expressing CD4+ T helper cells (Th17 cells) 
is of pivotal importance during malaria but the actual outcome of the immune 
response against the malaria parasite is dependent on the Treg/Th-17 balance, 
which is maintained majorly by TGFβ and IL-6.
4.  Role of plasmacytoid dendritic cells (pDC) and myeloid dendritic 
cells (mDC) in regulation of Treg/Th-17 balance in malaria
Dendritic cells (DC), a professional antigen presenting cell, function as a bridge 
between innate and adaptive immune responses. In various infections, including 
malaria, different subsets of dendritic cells and co-stimulatory molecules (CD40, 
CD80, CD86, MHC-II etc.) expressed by them show significant changes which 
indicates that dendritic cells play a major role in the regulation of T cell differ-
entiation and function [64]. Among different subsets, plasmacytoid DC (pDC), 
specially the tolerogenic pDCs induces and regulates the function of T regulatory 
cells [65]. Myeloid DC (mDC), on the other hand mainly secretes factors which 
are important for differentiation of Th-17 cells from naïve CD4+ T cells in several 
inflammatory disorders. Regulation of mDC function by several microRNA or 
other factors has its effect on Th-17 induction and function [66, 67]. In malaria, 
it has already been reported that mDC/pDC ratio has an impact on host immune 
response against Plasmodium sp. and disease pathogenesis [68, 69]. Analysis of 
splenic mDC/pDC ratio in Plasmodium berghei ANKA infection has shown that 
the ratio is increased significantly and the result is consistent with Th-17 mediated 
response against the murine cerebral malaria. This increased mDC/pDC ratio has 
been shown to revert back to homeostatic levels upon neutralization of IL-6, which 
also has its impact on Th-17 cells and functions in controlling the disease progres-
sion as discussed earlier [57]. Thus mDC/pDC ratio may be crucial in serving 
as a mediator that regulates the T-reg/Th-17 ratio in malaria. However, further 
investigation is still required to actually find out how exactly mDC/pDC ratio regu-
lates the T-reg/Th-17 balance and how it influences the outcome of the immune 
response against malaria parasite.
5.  Role of autophagy in the regulation of T-reg/Th17 balance in malaria 
infection
Autophagy is a well-known process which plays a beneficial role against infec-
tious disease not only by degrading pathogens but also by activating host immune 
system. Autophagy plays an important role in multiple aspects of immune system 
like cytokine balance, modulation of immune cells, innate and adaptive immunity 
and antigen presentation [70]. In our study we have found increased expression of 
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all five major markers of autophagy pathway viz. BECLIN1, ATG3, ATG5, ATG7, 
p62 with the progression of disease and the expressions were highest at 8 dpi 
Plasmodium berghei ANKA infection. An increase in the expression of LC3B has also 
been found. Simultaneously, the ratio of LC3B:LC3A increased at 8 dpi Plasmodium 
berghei ANKA infection which indicates the conversion of LC3A to LC3B and an 
upregulation of autophagic flux [71]. It has been reported that pDC harbours 
live Plasmodium parasite which have the ability to cause malaria symptoms when 
transferred to naïve mice [72]. Rapamycin (known autophagy inducer) treatment 
reduces the plasmodium load in splenic pDC. Autophagic induction increases the 
expression of CD205 and MHC I on pDC which stimulates antigen processing 
and antigen presentation respectively as compared to non-treated PbA infected 
group. Relative downregulation of proinflammatory cytokines like IL-6 and TNFα 
and positive induction of anti-inflammatory cytokines like IL10 was observed in 
autophagy induced mice. A tilt towards low Treg/Th-17 and high mDC/pDC ratio 
have been observed during malaria infection which induce Th1 pathway mediated 
immune regulation and poor prognosis for host. But autophagy induction can shift 
the Treg/Th17 balance towards increased T-reg population along with increased 
pDC population which can alter the mDC/pDC ratio, suppress the proinflamma-
tory response and promote Th2 pathway [73]. Autophagic regulation of splenic 
red pulp macrophages show similar results in context to Treg/Th-17 balance [74]. 
Upregulation of proinflammatory cytokines production and alteration of Treg/Th-17 
balance towards increased population of Th17 is a major cause for poor prognosis of 
malaria. Autophagy induction can revert the imbalance and help in betterment of 
host immune response.
6. Conclusion and future perspectives
Despite of continuous efforts towards invention of a proper and effective 
vaccines for malaria prevention, very few of them have their impact on reducing 
the number of malaria cases and malaria induced mortality. ACT still is the major 
therapeutic strategy in combating this disease, although emergence of Artemisinin 
resistance has been a major worry for the effectiveness of ACT during treatment 
of malaria patients. Immunotherapeutic strategies have been quite promising in 
several inflammatory disorders, cancers, autoimmune disorders and other infec-
tions. In case of malaria, although immunomodulation is very effective in murine 
studies, causing declination of parasitemia and increasing the survival percentages, 
application of those immunotherapeutic strategies in human is still awaiting. The 
balance between two T helper cell subsets i.e. T regulatory cells and Th-17 cells has 
been found to be important in both lethal and non-lethal malaria and factors which 
regulate this balance seems to play a pivotal role in disease manifestation. Studies 
using murine models has been quite effective in determining the factors and how 
they influence the disease outcome by regulating the Treg/Th-17 balance. Among 
those factors, TGFβ and IL-6 directly regulate the percentage of cells, expression 
of their characteristic transcription factors and functional cytokines secreted 
by Treg and Th-17 cells. Neutralization of IL-6 has direct effect on parasitaemia 
and survival percentages of mice infected with Plasmodium sp. It also reverses 
the dysregulated Treg/Th-17 ratio to optimal levels and can be a target for future 
therapeutic interventions against malaria infection. mDC/pDC ratio also play the 
role of a regulator and as a bridge to control Treg/Th-17 ratio. IL-6 neutralization 
can also bring the altered mDC/pDC ratio to normal levels. Apart from these, 
autophagic regulation of dendritic cells and macrophages in the spleen has its effect 
on Treg/Th-17 balance. Though, use of T-regulatory cells and drugs that directly 
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regulate the altered ratio is regarded as a potentially attractive therapeutic strategy 
in autoimmune disorders, application of these approaches in malaria and other 
parasitic infections needs more attention and caution. Further investigations are 
still required to achieve the goal of a malaria free world.
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